Acute Pulmonary Embolism

In suspected acute PE, first establish whether shock, cardiac arrest, persistent hypotension, or evolving cardiopulmonary failure is present. The 2026 multisociety guideline organizes acute PE severity using clinical, hemodynamic, respiratory, biomarker, and right-ventricular parameters, progressing from asymptomatic disease through low-severity symptomatic PE, elevated-severity PE, incipient cardiopulmonary failure, and persistent-hypotension cardiopulmonary failure. jacc+1jacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ...jacc2026 Acute Pulmonary Embolism Guideline-at-a-Glance

For an unstable patient in whom CTPA is not feasible, bedside echocardiography is an accepted adjunctive diagnostic strategy; it should support urgent management rather than delay resuscitation or definitive imaging when feasible. ACCACCCover Story | Pulmonary Embolism: A Clinical Approach

CT pulmonary angiography is the primary diagnostic test for acute PE across major guidelines. V/Q scanning is preferred or useful when CTPA is contraindicated or unavailable. ACCACCCover Story | Pulmonary Embolism: A Clinical Approach The choice should account for contrast exposure, renal function, radiation considerations, local access, and whether another chest diagnosis is likely to be clarified by CTPA; specific thresholds for these considerations are not provided in the supplied sources.

D-dimer is most useful when the pretest probability is not high. A prospective management study evaluated D-dimer thresholds adjusted for clinical pretest probability with the goal of reducing unnecessary CTPA while identifying patients who can safely avoid anticoagulation and imaging. NEJMNEJMDiagnosis of Pulmonary Embolism with d-Dimer Adjusted ... Do not use a negative D-dimer result as a stand-alone exclusion strategy without first establishing a low or intermediate clinical probability framework.

In patients with confirmed PE, evaluate prognosis beyond clot location. Current approaches integrate clinical severity assessment with biomarkers and imaging evidence of right-ventricular abnormality. PESI or simplified PESI remain commonly used validated clinical risk tools in guideline-based practice. ACCACCCover Story | Pulmonary Embolism: A Clinical Approach

Validated clinical scores, particularly PESI and simplified PESI, are used to identify lower-risk patients after PE confirmation. ACCACCCover Story | Pulmonary Embolism: A Clinical Approach The 2026 multisociety framework further emphasizes that clinical severity should be interpreted alongside respiratory status, hemodynamics, cardiac biomarkers, and right-ventricular size and function. jacc+1jacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ...jacc2026 Acute Pulmonary Embolism Guideline-at-a-Glance

Outpatient management is not simply a low clot-burden decision. It requires low predicted early complication risk, no need for reperfusion or inpatient supportive care, acceptable bleeding risk, reliable medication access, and follow-up infrastructure. The newer multisociety summary supports emergency department discharge for asymptomatic PE and generally supports early discharge for symptomatic patients with low clinical severity. jaccjacc2026 Acute Pulmonary Embolism Guideline-at-a-Glance

The purpose of diagnostic evaluation is to identify patients with PE who are expected to benefit from anticoagulant treatment and to avoid treatment in patients without PE or with disease unlikely to progress. NEJMNEJMDiagnosis of Pulmonary Embolism with d-Dimer Adjusted ... Contemporary PE guidance includes pharmacologic therapy across acute and early post-acute care, but the supplied search results do not provide drug-specific U.S. dosing, renal adjustments, duration recommendations, or selection criteria among direct oral anticoagulants, heparins, and warfarin. jaccjacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ...

Use an anticoagulant regimen consistent with current institutional protocols, FDA labeling, and patient-specific factors including hemodynamic stability, anticipated invasive therapy, renal function, hepatic disease, pregnancy, active cancer, drug interactions, adherence, and bleeding risk. These selection details require source verification because they are not specified in the supplied excerpts.

Patients with PE presenting with shock, arrest, or persistent hypotension have the clearest need for urgent consideration of reperfusion and advanced support strategies. Earlier AHA statements and interventional reviews describe systemic fibrinolysis, catheter-assisted embolectomy, surgical embolectomy, and, in selected circumstances, IVC filter placement as advanced treatment options. AHA Journals+3AHA JournalsManagement of Submassive Pulmonary EmbolismAHA JournalsInterventional Therapies for Acute Pulmonary EmbolismAHA JournalsInterventional Treatment of Pulmonary Embolism | CirculationAHA JournalsManagement of Massive and Submassive Pulmonary ...

For normotensive patients with right-ventricular dysfunction or biomarker elevation, routine escalation should not be inferred from either finding alone. The newer framework distinguishes elevated-severity PE from incipient cardiopulmonary failure and persistent-hypotension failure, reinforcing the need to identify clinical trajectory rather than treating all intermediate-risk phenotypes alike. jacc+1jacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ...jacc2026 Acute Pulmonary Embolism Guideline-at-a-Glance

Catheter-directed and mechanical interventions have expanded, but patient selection remains a central uncertainty. The supplied sources establish their role as available options and emphasize appropriate risk stratification; they do not provide sufficiently detailed comparative outcomes, device-specific indications, or contraindication criteria to support prescriptive device selection. AHA Journals+1AHA JournalsInterventional Therapies for Acute Pulmonary EmbolismScienceDirectTreatment of acute pulmonary embolism: a comparison ...

The 2026 multisociety guideline addresses care from symptom onset through clinical follow-up and includes acute and early post-acute management. jaccjacc2026 AHA/ACC/ACCP/ACEP/CHEST/SCAI/SHM/SIR/SVM/ ... Patients discharged early require a defined follow-up plan that verifies anticoagulant access and adherence, reassesses bleeding and recurrent-thrombosis symptoms, and evaluates persistent dyspnea or functional limitation.

Persistent symptoms after PE should prompt evaluation for alternative cardiopulmonary disease and, when clinically appropriate, chronic thromboembolic pulmonary hypertension. The supplied sources identify chronic thromboembolic pulmonary hypertension as a PE-related management domain but do not provide a follow-up interval or diagnostic algorithm. AHA Journals+1AHA JournalsManagement of Massive and Submassive Pulmonary ...Oxford Academic2019 ESC Guidelines for the diagnosis and management of ...